X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9993) 9993
Publication (946) 946
Book Chapter (65) 65
Book Review (46) 46
Conference Proceeding (12) 12
Dissertation (4) 4
Web Resource (3) 3
Magazine Article (2) 2
Paper (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7055) 7055
chemoradiation (5982) 5982
index medicus (5854) 5854
oncology (5419) 5419
female (5230) 5230
middle aged (4860) 4860
male (4760) 4760
aged (4479) 4479
chemotherapy (4180) 4180
radiotherapy (4174) 4174
cancer (4167) 4167
surgery (3985) 3985
adult (3377) 3377
chemoradiotherapy (2922) 2922
treatment outcome (2691) 2691
neoplasm staging (2259) 2259
care and treatment (2197) 2197
survival (2064) 2064
carcinoma (2043) 2043
radiation-therapy (1993) 1993
retrospective studies (1959) 1959
aged, 80 and over (1941) 1941
combined modality therapy (1892) 1892
neoadjuvant therapy (1825) 1825
radiology, nuclear medicine & medical imaging (1751) 1751
prognosis (1720) 1720
therapy (1600) 1600
antineoplastic combined chemotherapy protocols - therapeutic use (1476) 1476
squamous-cell carcinoma (1459) 1459
radiation (1395) 1395
rectal cancer (1328) 1328
adenocarcinoma (1287) 1287
medicine & public health (1275) 1275
disease-free survival (1186) 1186
esophageal cancer (1182) 1182
analysis (1154) 1154
survival rate (1146) 1146
gastroenterology & hepatology (1110) 1110
preoperative chemoradiation (1102) 1102
rectal neoplasms - pathology (1096) 1096
research (1072) 1072
radiation therapy (1048) 1048
hematology, oncology and palliative medicine (1030) 1030
rectal neoplasms - therapy (1014) 1014
follow-up studies (1007) 1007
chemoradiation therapy (988) 988
cisplatin (966) 966
colorectal cancer (941) 941
trial (926) 926
adenocarcinoma - therapy (904) 904
fluorouracil - administration & dosage (878) 878
survival analysis (875) 875
chemotherapy, adjuvant (866) 866
health aspects (865) 865
carcinoma, squamous cell - therapy (852) 852
adenocarcinoma - pathology (845) 845
carcinoma, squamous cell - pathology (838) 838
patients (827) 827
radiotherapy dosage (822) 822
squamous cell carcinoma (781) 781
randomized-trial (775) 775
pancreatic cancer (764) 764
prospective studies (733) 733
cisplatin - administration & dosage (726) 726
tumors (724) 724
radiotherapy, adjuvant (723) 723
neoadjuvant chemoradiation (708) 708
esophageal neoplasms - therapy (706) 706
esophageal neoplasms - pathology (679) 679
head and neck cancer (654) 654
preoperative chemoradiotherapy (644) 644
total mesorectal excision (638) 638
carcinoma, squamous cell - radiotherapy (635) 635
risk factors (625) 625
toxicity (624) 624
rectal neoplasms - surgery (622) 622
patient outcomes (618) 618
abridged index medicus (616) 616
phase-iii trial (616) 616
carcinoma, squamous cell - mortality (609) 609
resection (606) 606
adjuvant treatment (603) 603
cancer therapies (574) 574
metastasis (573) 573
fluorouracil (571) 571
carcinoma, squamous cell - drug therapy (567) 567
chemoradiotherapy - methods (562) 562
antineoplastic agents - therapeutic use (557) 557
otorhinolaryngology (556) 556
rectal neoplasms - radiotherapy (547) 547
lymphatic metastasis (545) 545
oncology, experimental (543) 543
cancer patients (538) 538
adenocarcinoma - mortality (523) 523
adenocarcinoma - surgery (519) 519
kaplan-meier estimate (519) 519
gemcitabine (511) 511
head (509) 509
radiology (504) 504
cervical cancer (498) 498
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9632) 9632
French (158) 158
German (154) 154
Korean (34) 34
Japanese (33) 33
Spanish (27) 27
Russian (8) 8
Italian (7) 7
Polish (4) 4
Hungarian (2) 2
Chinese (1) 1
Czech (1) 1
Dutch (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Persian (1) 1
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
Journal Article
CA Cancer Journal for Clinicians, ISSN 0007-9235, 11/2012, Volume 62, Issue 6, pp. 400 - 422
Oral complications resulting from cancer and cancer therapies cause acute and late toxicities that may be underreported, underrecognized, and undertreated.... 
head and neck neoplasms | mucositis | hematopoietic cell transplantation | radiation | hyposalivation | oral neoplasms | osteonecrosis | xerostomia | chemoradiation | chemotherapy | SUBMANDIBULAR SALIVARY-GLAND | VERSUS-HOST-DISEASE | PATIENT-REPORTED OUTCOMES | CLINICAL-PRACTICE GUIDELINES | MODULATED RADIATION-THERAPY | ONCOLOGY GROUP RTOG | NECK SYMPTOM SURVEY | ONCOLOGY | LOCALLY ADVANCED HEAD | QUALITY-OF-LIFE | STEM-CELL TRANSPLANTATION | Humans | Candidiasis, Oral - etiology | Oral Ulcer - etiology | Radiotherapy - adverse effects | Sialorrhea - therapy | Osteoradionecrosis - etiology | Dose-Response Relationship, Drug | Olfaction Disorders - therapy | Neoplasms, Second Primary | Osteoradionecrosis - therapy | Antineoplastic Agents - adverse effects | Tooth Demineralization - etiology | Sialorrhea - etiology | Taste Disorders - therapy | Facial Pain - etiology | Dental Caries - prevention & control | Severity of Illness Index | Trismus - etiology | Dental Caries - etiology | Risk Factors | Head and Neck Neoplasms - therapy | Neoplasm Recurrence, Local | Virus Diseases - therapy | Trismus - therapy | Stomatitis - etiology | Taste Disorders - etiology | Virus Diseases - etiology | Candidiasis, Oral - therapy | Periodontitis - etiology | Stomatitis - therapy | Oral Ulcer - therapy | Tooth Demineralization - prevention & control | Facial Pain - therapy | Quality of Life | Oral Health | Olfaction Disorders - etiology | Causes of | Complications and side effects | Mouth diseases | Care and treatment | Cancer | Surgical outcomes | Oncology | Chemotherapy | Toxicity | Cells
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 06/2017, Volume 17, Issue 1, pp. 401 - 10
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 06/2017, Volume 98, Issue 2, pp. 400 - 408
NRG Oncology RTOG 0529 assessed the feasibility of dose-painted intensity modulated radiation therapy (DP-IMRT) to reduce the acute morbidity of chemoradiation... 
RECTAL-CANCER | ONCOLOGY | SMALL-BOWEL TOXICITY | VOLUME RELATIONSHIPS | CHEMORADIATION | CHEMORADIOTHERAPY | MITOMYCIN | RADIOTHERAPY | COMBINATION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | Organs at Risk - radiation effects | Chemoradiotherapy - adverse effects | Age Factors | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Pelvis - diagnostic imaging | Radiotherapy, Intensity-Modulated - adverse effects | Feasibility Studies | Organs at Risk - pathology | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Anus Neoplasms - therapy | Adult | Female | Intestine, Small - radiation effects | Mitomycin - adverse effects | Radiotherapy Dosage | Acute Disease | Chemoradiotherapy - methods | Anus Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Anus Neoplasms - pathology | Tumor Burden | Regression Analysis | Colon - diagnostic imaging | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Organs at Risk - diagnostic imaging | Intestine, Small - diagnostic imaging | ROC Curve | Aged | Mitomycin - administration & dosage | Analysis | Anal cancer | Radiation | Information management | Radiotherapy | Cancer | Fluorouracil | Oncology, Experimental | Research | Index Medicus | AUGER ELECTRON SPECTROSCOPY | LARGE INTESTINE | PATIENTS | DISEASE INCIDENCE | NEOPLASMS | RADIATION HAZARDS | PERFORMANCE | RADIATION DOSES | FLUORINE COMPOUNDS | GY RANGE 10-100 | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 6/2011, Volume 18, Issue 6, pp. 1590 - 1598
Journal Article